Stephanie Gasking Clinical Oncology Society of Australia Annual Scientific Meeting 2024

Abstracts this author is presenting:

• Health-related quality of life (HRQoL) with tepotinib in patients with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) with brain, liver, adrenal or bone metastases in the Phase II VISION trial — Afternoon Tea, Exhibition & Poster Session 1